Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93.

Ueda SM, Mao TL, Kuhajda FP, Vasoontara C, Giuntoli RL, Bristow RE, Kurman RJ, Shih IeM.

Am J Pathol. 2009 Dec;175(6):2618-24. doi: 10.2353/ajpath.2009.081162.

2.

Immunobiology of complete molar pregnancy and gestational trophoblastic tumor.

Berkowitz RS, Umpierre SA, Taylor-Emery S, Goldstein DP, Anderson DJ.

Cancer Metastasis Rev. 1986;5(2):109-23. Review.

PMID:
3030577
3.
6.
7.

Gestational trophoblastic disease. New approaches to diagnosis.

Lage JM, Wolf NG.

Clin Lab Med. 1995 Sep;15(3):631-64. Review.

PMID:
8542727
8.
9.

Histologic classification and staging of gestational trophoblastic disease.

Horn LC, Bilek K.

Gen Diagn Pathol. 1997 Nov;143(2-3):87-101. Review.

PMID:
9443566
10.

[Potential role of the angiogenic factor "EG-VEGF" in gestational trophoblastic diseases].

Boufettal H, Feige JJ, Benharouga M, Aboussaouira T, Nadifi S, Mahdaoui S, Samouh N, Alfaidy N.

Pathol Biol (Paris). 2013 Oct;61(5):178-83. doi: 10.1016/j.patbio.2013.02.001. Review. French.

PMID:
23647696
11.

Fatty acid synthase as a potential therapeutic target in cancer.

Flavin R, Peluso S, Nguyen PL, Loda M.

Future Oncol. 2010 Apr;6(4):551-62. doi: 10.2217/fon.10.11. Review.

12.

Fatty acid synthase - Modern tumor cell biology insights into a classical oncology target.

Buckley D, Duke G, Heuer TS, O'Farrell M, Wagman A, McCulloch W, Kemble G.

Pharmacol Ther. 2017 Feb 12. pii: S0163-7258(17)30035-9. doi: 10.1016/j.pharmthera.2017.02.021. [Epub ahead of print] Review.

Items per page

Supplemental Content

Support Center